Hib Immunization Bibliography


[no Author]
Introduction of Hib vaccine in the Americas: lessons learned.
EPI Newsl (United States), Apr 1999, 21(2) p4-5

Advisory Committee on Immunization Practices
Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates--assessment and feedback of provider-based vaccination coverage information.
MMWR Morb Mortal Wkly Rep (United States), Mar 15 1996, 45(10) p219-20

Baker CJ, Edwards MS.
Group B streptococcal conjugate vaccines.
Arch Dis Child. 2003 May;88(5):375-8. Review.

Capiau C, Poolman J, Hoet B, Bogaerts H, Andre F.
Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned.
Vaccine. 2003 Jun 2;21(19-20):2273-87.

Chapman RW, Hacker TW
Calculating a clinic's childhood immunization rate. Costs and returns.
Arch Fam Med (United States), Jul 1995, 4(7) p625-7

Cochi SL, Broome CV, Hightower AW
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
JAMA (United States), Jan 25 1985, 253(4) p521-9

Cohen NJ, Lauderdale DS, Shete PB, Seal JB, Daum RS.
Physician knowledge of catch-up regimens and contraindications for childhood immunizations.
Pediatrics. 2003 May;111(5 Pt 1):925-32.

Daum RS, Granoff DM
A vaccine against Haemophilus influenzae type b.
Pediatr Infect Dis (United States), Jul-Aug 1985, 4(4) p355-7

Gabutti G, Bona G, et al.
Immunogenicity and reactogenicity following primary immunization with a combined DTaP-HBV vaccine and a haemophilus influenzae type b vaccine administered by separate or mixed injection. 
Clinical Drug Investigator 2005;25(5):315-323.

Glauber JH.
The immunization delivery effectiveness assessment score: a better immunization measure?
Pediatrics. 2003 Jul;112(1 Pt 1):e39-45.

Goldstein KP, Lauderdale DS, Glushak C, et al.
Immunization outreach in an inner-city housing development: reminder-recall on foot.
Pediatrics (United States), Dec 1999, 104(6) pe69

Back to top

Grabenstein JD
Low immunization rates in ethnic minorities--a problem pharmacists can help solve.
J Am Pharm Assoc (Wash) (United States), Sep-Oct 1999, 39(5) p708

Cochi SL, Broome CV, Hightower AW
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
JAMA (United States), Jan 25 1985, 253(4) p521-9

Hay JW, Daum RS
Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
Pediatrics (United States), Sep 1987, 80(3) p319-29

Hesley TM, Reisinger KS, et al. 
Concomitant administration of a bivalent Haemophilius influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity. 
Pediatric Infectious Disease Journal 2004;23:240-5.

Herrera GA, Smith P, Daniels D, et al.
National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1998.
MMWR CDC Surveill Summ (United States), Sep 22 2000, 49(9) p1-26

Hutchins SS, Sherrod J, Bernier R
Assessing immunization coverage in private practice.
J Natl Med Assoc (United States), Apr 2000, 92(4) p163-8

Kanra G, Viviani S, Yurdakok K, Ozmert E, Anemona A, Yalcin S, Demiralp O, Bilgili N, Kara A, Cengiz AB, Mutlu B, Baldini A, Marchetti E, Podda A.
Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b CRM197 conjugate vaccine.
Pediatr Int. 2003 Jun;45(3):314-8.

Kolasa MS, Chilkatowsky AP, Stevenson JM, Lutz JP, Watson BM, Levenson R, Rosenthal J.
Do laws bring children in child care centers up to date for immunizations?
Ambul Pediatr. 2003 May-Jun;3(3):154-7.

Koepke CP, Vogel CA, Kohrt AE
Provider characteristics and behaviors as predictors of immunization coverage.
Am J Prev Med (Netherlands), Nov 2001, 21(4) p250-5

Kohrt AE, Kohrt LG
Improving immunization rates in pediatric practice.
Pediatr Ann (United States), Jun 2001, 30(6) p320-7

Lagos R, Munoz A, Dumas R, Pichon S, Zambrano B, Levine M, Vidor E.
Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
Vaccine. 2003 Sep 8;21(25-26):3730-3.

Back to top

Lifson AR, Roddy M, Ehresmann KR
The association of poverty and low immunization rates in ZIP code areas. A retrospective survey of Minnesota kindergartners.
Minn Med (United States), Aug 2000, 83(8) p51-5

Makela PH, Kayhty H.
Evolution of conjugate vaccines.
Expert Rev Vaccines. 2002 Oct;1(3):399-410. Review.

Midani S, Ayoub EM, Rathore MH
Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.
J Fla Med Assoc (United States), Jun 1995, 82(6) p401-2

Moulton LH, Chung S, Croll J, et al.
Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population.
Int J Epidemiol (England), Aug 2000, 29(4) p753-6

Obaro SK, Enwere GC, Deloria M, et al.
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine.
Pediatr Infect Dis J (United States), Oct 2002, 21(10) p940-7

Ramsay ME, McVernon J, Andrews NJ, Heath PT, Slack MP.
Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.
J Infect Dis. 2003 Aug 15;188(4):481-5.

Rathore MH, Dick M, Buckner P, et al.
Haemophilus influenzae type B invasive disease in urban and rural children: immunization patterns and prevalence of disease.
South Med J (United States), Nov 1994, 87(11) p1083-7

Rodewald LE, Szilagyi PG, Humiston SG, et al.
A randomized study of tracking with outreach and provider prompting to improve immunization coverage and primary care.
Pediatrics (United States), Jan 1999, 103(1) p31-8

Singleton RJ, Davidson NM, Desmet IJ, et al.
Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization.
Pediatr Infect Dis J (United States), May 1994, 13(5) p362-7

Back to top

Sinn JS, Morrow AL, Finch AB
Improving immunization rates in private pediatric practices through physician leadership.
Arch Pediatr Adolesc Med (United States), Jun 1999, 153(6) p597-603

Strine TW, Barker LE, Mokdad AH, et al.
Vaccination coverage of foreign-born children 19 to 35 months of age: findings from the National Immunization Survey, 1999-2000.
Pediatrics (United States), Aug 2002, 110(2 Pt 1) pe15

Szilagyi PG, Schaffer S, Shone L, et al.
Reducing geographic, racial, and ethnic disparities in childhood immunization rates by using reminder/recall interventions in urban primary care practices.
Pediatrics (United States), Nov 2002, 110(5) pe58

Vadheim CM, Greenberg DP, Marcy SM, et al.
Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children.
Pediatr Infect Dis J (United States), Aug 1990, 9(8) p555-61

Ward JI
Is Hemophilus influenzae type b disease preventable?
JAMA (United States), Jan 25 1985, 253(4) p554-6

Zhou F, Bisgard KM, Yusuf HR, et al.
Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
Pediatrics (United States), Oct 2002, 110(4) p653-61

Back to top